Ameet Mallik

CEO

ADC Therapeutics SA (ADCT)

Board Member

ADC Therapeutics SA (ADCT)

Board Member

Rafael Holdings, Inc. (RFL)

CEO

Rafael Holdings, Inc. (RFL)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Rafael Holdings, Inc. (RFL)
Board Member

SEC 8-K

Current
2021-06-14–present
Rafael Holdings, Inc. (RFL)
CEO

SEC 8-K

Current
2021-05-01–present
ADC Therapeutics SA (ADCT)
CEO

Proxy statement

Current
ADC Therapeutics SA (ADCT)
Board Member

Proxy statement

Current
Rafael Holdings, Inc. (RFL)
Board Member

Proxy statement

Start not stated–2022-05-29
Rafael Holdings, Inc. (RFL)
CEO

Proxy statement

Start not stated–2022-01-31

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

ADC Therapeutics SA

ADCT

Current role

CEO, Board Member

17 calls Latest call 2026-06-03

View earnings calls

Rafael Holdings, Inc.

RFL

Current role

Board Member, CEO

2021-05-01–present

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	ADC Therapeutics SA (ADCT)	Chief Executive Officer Jose “Pepe” Carmona Chief Financial Officer	$776,084	—	$1,046,500	—	$582,063	$48,503	$2,453,150
2024	ADC Therapeutics SA (ADCT)	Chief Executive Officer Jose “Pepe” Carmona Chief Financial Officer	$746,235	$621,732	—	—	$425,354	$44,307	$1,837,628
2023	ADC Therapeutics SA (ADCT)	Chief Executive Officer Jose “Pepe” Carmona Chief Financial Officer	$721,000	$705,065	$1,059,300	$881,250	$367,710	$45,100	$3,779,425
2022	Rafael Holdings, Inc. (RFL)	Former Chief Executive Officer	$300,000	$150,000	—	—	—	$5,000,000	$5,450,000
2021	Rafael Holdings, Inc. (RFL)	Former Chief Executive Officer	$150,000	$2,075,000	$45,097,191	—	—	—	$47,332,791

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Earnings call ADC Therapeutics SA Q1 FY2026 Earnings Call ADC Therapeutics SA (ADCT)
2026-06-03
Earnings call ADC Therapeutics SA Q4 FY2025 Earnings Call ADC Therapeutics SA (ADCT)
2026-03-10
Earnings call ADC Therapeutics SA Q3 FY2025 Earnings Call ADC Therapeutics SA (ADCT)
2025-11-03
Earnings call ADC Therapeutics SA Q2 FY2025 Earnings Call ADC Therapeutics SA (ADCT)
2025-08-12
Earnings call ADC Therapeutics SA Q1 FY2025 Earnings Call ADC Therapeutics SA (ADCT)
2025-05-14
Earnings call ADC Therapeutics SA Q4 FY2024 Earnings Call ADC Therapeutics SA (ADCT)
2025-01-13
Earnings call ADC Therapeutics SA Q3 FY2024 Earnings Call ADC Therapeutics SA (ADCT)
2024-11-07
Earnings call ADC Therapeutics SA Q2 FY2024 Earnings Call ADC Therapeutics SA (ADCT)
2024-08-06
Earnings call ADC Therapeutics SA Q1 FY2024 Earnings Call ADC Therapeutics SA (ADCT)
2024-05-06
Earnings call ADC Therapeutics SA Q4 FY2023 Earnings Call ADC Therapeutics SA (ADCT)
2024-01-04
Earnings call ADC Therapeutics SA Q3 FY2023 Earnings Call ADC Therapeutics SA (ADCT)
2023-09-30
Earnings call ADC Therapeutics SA Q2 FY2023 Earnings Call ADC Therapeutics SA (ADCT)
2023-06-30

Show 5 earlier activities

Earnings call ADC Therapeutics SA Q1 FY2023 Earnings Call ADC Therapeutics SA (ADCT)
2023-03-31
Earnings call ADC Therapeutics SA Q4 FY2022 Earnings Call ADC Therapeutics SA (ADCT)
2022-12-31
Earnings call ADC Therapeutics SA Q3 FY2022 Earnings Call ADC Therapeutics SA (ADCT)
2022-09-30
Earnings call ADC Therapeutics SA Q2 FY2022 Earnings Call ADC Therapeutics SA (ADCT)
2022-06-30
Earnings call ADC Therapeutics SA Q1 FY2022 Earnings Call ADC Therapeutics SA (ADCT)
2022-03-31